[1] Wang LH, Yu W, Yin XJ, et al.Prevalence of osteoporosis and fracture in China: The China osteoporosis prevalence study[J]. JAMA Netw Open, 2021, 4(8): e2121106. [2] Wu X, Li X, Xu MH, et al.Sarcopenia prevalence and associated factors among older Chinese population: Findings from the China Health and Retirement Longitudinal Study[J]. PLoS One, 2021, 16(3): e0247617. [3] vSong JD, Zhao JX, Liu T, et al. Prevalence and risk factors of osteoporosis in a Chinese population: A cross-sectional study in Xi'an, Shaanxi Province, China[J]. Med Sci Monit, 2023, 29: e942346. [4] 袁玲丹,宋利格. 《原发性骨质疏松症诊疗指南(2022版)》解读[J]. 同济大学学报(医学版),2023,44(6):777-784. [5] Eghbali T, Abdi K, Nazari M, et al.Prevalence of osteoporosis among Iranian postmenopausal women: A systematic review and meta-analysis[J]. Clin Med Insights Arthritis Musculoskelet Disord, 2022, 15: 11795441211072471. [6] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2022)[J]. 中华骨质疏松和骨矿盐疾病杂志,2022,15(6):573-611. [7] Ji JZ, Hou Y, Li ZY, et al.Association between physical activity and bone mineral density in postmenopausal women: A cross-sectional study from the NHANES 2007-2018[J]. J Orthop Surg Res, 2023, 18(1): 501. [8] 许忆浪. 岭南地区骨质疏松知识评价问卷(Osteoporosis Knowledge Assessment Questionnaire,OKAQ)的改进与完善[D]. 广州:广州中医药大学,2022. [9] 谭雅琼,罗碧华. 骨质疏松症认知评估的测量[J]. 中国骨质疏松杂志,2020,26(11):1713-1716. [10] Demay MB, Pittas AG, Bikle DD, et al.Vitamin D for the prevention of disease: An Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab, 2024, 109(8): 1907-1947. [11] 尹艳华,林永强,吴静,等. 上海市松江区九亭地区老年人骨质疏松患病状况及危险因素分析[J]. 中华预防医学杂志,2024,58(7):1048-1054. [12] 门鑫,刘名名,王慧. 老年骨质疏松症患者腰椎间盘突出症的影响因素分析[J]. 预防医学,2024,36(11):1000-1002,1007. [13] 苟静,岳建彪,易松,等. 成都市60岁及以上老年人群骨质疏松影响因素及相关知识知晓程度调查[J]. 实用预防医学,2022,29(7):782-786. [14] 汤淑女,尹香君,余卫,等. 中国老年人骨质疏松症知识知晓及影响因素分析[J]. 中国健康教育,2023,39(3):200-205. [15] Xiao PL, Cui AY, Hsu CJ, et al.Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: A systematic review and meta-analysis[J]. Osteoporos Int, 2022, 33(10): 2137-2153. [16] Bhattarai HK, Shrestha S, Rokka K, et al.Vitamin D, calcium, parathyroid hormone, and sex steroids in bone health and effects of aging[J]. J Osteoporos, 2020, 2020: 9324505. [17] Iantomasi T, Romagnoli C, Palmini G, et al.Oxidative stress and inflammation in osteoporosis: Molecular mechanisms involved and the relationship with microRNAs[J]. Int J Mol Sci, 2023, 24(4): 3772. [18] 刘功稳,朱柯雨,陆政峰,等. 骨质疏松症和骨质疏松性骨折防治的现状及挑战[J]. 中华骨质疏松和骨矿盐疾病杂志,2024,17(5):409-418. [19] 段蔚宇,张莹,陆艳,等. 苏州市相城区50岁以上女性骨质疏松症影响因素分析[J]. 中国煤炭工业医学杂志,2024,27(6):597-603. [20] 王梦琴,崔翔,曹杰,等. 北京市社区人群慢性骨病的患病情况及影响因素[J]. 中国慢性病预防与控制,2024,32(8):593-598. [21] 余文慧,赵辉,阿娜尔·高少,等. 成年人骨质疏松症相关体质指数的临界值研究[J]. 新疆医科大学学报,2024,47(7):1032-1036. [22] Forte YS, Renovato-Martins M, Barja-Fidalgo C.Cellular and molecular mechanisms associating obesity to bone loss[J]. Cells, 2023, 12(4): 521. [23] Chevalley T, Brandi ML, Cashman KD, et al.Role of vitamin D supplementation in the management of musculoskeletal diseases: Update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group[J]. Aging Clin Exp Res, 2022, 34(11): 2603-2623. [24] Voulgaridou G, Papadopoulou SK, Detopoulou P, et al.Vitamin D and calcium in osteoporosis, and the role of bone turnover markers: A narrative review of recent data from RCTs[J]. Diseases, 2023, 11(1): 29. [25] 倪泽敏,刘倩,蔡翠华,等. 维生素及联合钙摄入与原发骨质疏松症风险关联性研究进展[J]. 中国社会医学杂志,2024,41(3):365-368. [26] 曹中萍,王芳,李贞,等. 郑州市≥60岁人群骨质疏松现状及影响因素分析[J]. 华南预防医学,2022,48(10):1278-1281. [27] 俞梅华,章奇,运靖宜,等. 老年人跌倒预防知识、态度和行为调查[J]. 预防医学,2024,36(10):851-855,860. [28] 李改娟,孙静. 山西省农村围绝经期女性骨质疏松症健康素养水平及影响因素[J]. 护理研究,2024,38(13):2270-2275. |